Northern Trust Corporation Form 8.3 - Allergan Plc (4986G)
November 20 2015 - 9:52AM
UK Regulatory
TIDMPFZ TIDMIRSH
RNS Number : 4986G
Northern Trust Corporation
20 November 2015
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing Northern Trust Group
(Note 1)
========================== ====================
Company dealt in Allergan Plc
========================== ====================
Class of relevant security Ordinary Shares
to which the dealings
being disclosed relate
(Note 2)
========================== ====================
Date of dealing (19th November 2015)
========================== ====================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant security dealt in (Note 3)
Long Short
=========================== =================== =====================
Number (%) Number (%)
=========================== ======= ==== ==== ========= ==== ====
(1) Relevant securities 4,453,356 1.13
=========================== =================== =====================
(2) Derivatives (other
than options)
=========================== =================== =====================
(3) Options and agreements
to purchase/sell
=========================== =================== =====================
Total 4,453,356 1.13
=========================== =================== =====================
* Note: The difference in holdings from yesterday and today not
explained by transactions, can be explained by stock transfers of
355 securities into the relevant accounts
(b) Interests and short positions in relevant securities of the
company, other than the class dealt in (Note 3)
Class of relevant security: Long Short
============================ =================== =====================
Number (%) Number (%)
============================ ======= ==== ==== ========= ==== ====
(1) Relevant securities
============================ =================== =====================
(2) Derivatives (other
than options)
============================ =================== =====================
(3) Options and agreements
to purchase/sell
============================ =================== =====================
Total
============================ =================== =====================
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (USD)
================ ====================================== ==========================
Buy 20 301.31
================ ====================================== ==========================
Buy 35 302.05
================ ====================================== ==========================
Buy 88 302.17
================ ====================================== ==========================
Buy 154 302.37
================ ====================================== ==========================
Buy 184 302.43
================ ====================================== ==========================
Buy 390 302.47
================ ====================================== ==========================
Buy 101 302.62
================ ====================================== ==========================
Buy 5 302.64
================ ====================================== ==========================
Buy 30 302.81
================ ====================================== ==========================
Buy 2 302.91
================ ====================================== ==========================
Buy 99 303.34
================ ====================================== ==========================
Buy 60 303.53
================ ====================================== ==========================
Sell 3 301.59
================ ====================================== ==========================
Sell 21 302.05
================ ====================================== ==========================
Sell 9 302.77
================ ====================================== ==========================
Sell 15 303.34
================ ====================================== ==========================
Sell 74 303.83
================ ====================================== ==========================
Buy 159 301.22
================ ====================================== ==========================
Buy 100 306.75
================ ====================================== ==========================
Buy 85 302.91
================ ====================================== ==========================
Sell 2 302.70
================ ====================================== ==========================
Sell 2 302.71
================ ====================================== ==========================
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
========= ===================== ================== ==========
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
========== ============ ============== ======== =============== ====== ====================
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
================= =========================== ===================
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
===================== ============== ====================
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any
relevant securities to which any derivative referred to on this
form is referenced. If none, this
should be stated.
N/A
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 20(th) November 2015
============================ =====================
Contact name Paul Adair
============================ =====================
Telephone number 020 7982 1236
============================ =====================
If a connected EFM, name N/A
of offeree/offeror with
which connected
============================ =====================
If a connected EFM, state N/A
nature of connection (Note
10)
============================ =====================
This information is provided by RNS
The company news service from the London Stock Exchange
END
ISEPKKDPQBDDKDB
(END) Dow Jones Newswires
November 20, 2015 09:52 ET (14:52 GMT)
Pfizer (LSE:PFZ)
Historical Stock Chart
From Oct 2024 to Nov 2024
Pfizer (LSE:PFZ)
Historical Stock Chart
From Nov 2023 to Nov 2024
